This purpose of this clinical research was to determine the efficacy and safety of an
experimental drug called Rilonacept in participants with an acute gout attack. Participants
participated in this study for 30 days. Rilonacept alone was being compared with Indomethacin
alone and the combination of Rilonacept plus Indomethacin in treating acute gout flares.